Skip to content
20-F

Annual Report (Foreign)

Adagene Inc. ADAG

0001410578-25-000419

← back to feed
Filed
Mar 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 31, 2024 58.89M sh
Long Term Debt FY 2024 · Dec 31, 2023 $13.54M
Short Term Debt FY 2024 · Dec 31, 2023 $8.4M
Short Term Investments FY 2024 · Dec 31, 2023 $0
Cash And Equivalents FY 2024 · Dec 31, 2023 $109.93M
Current Liabilities FY 2024 · Dec 31, 2023 $31.46M
Total Liabilities FY 2024 · Dec 31, 2023 $45.17M
Current Assets FY 2024 · Dec 31, 2023 $113.44M
Total Assets FY 2024 · Dec 31, 2023 $115.73M
Shares Diluted FY 2024 · Dec 31, 2022 54.14M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $3.98M
Capex FY 2024 · Dec 31, 2022 $690.94K
Operating Cash Flow FY 2024 · Dec 31, 2022 −$48.61M
Eps Diluted FY 2024 · Dec 31, 2022 −$1.48
Eps Basic FY 2024 · Dec 31, 2022 −$1.48
Sga Expense FY 2024 · Dec 31, 2022 $11.87M
Rd Expense FY 2024 · Dec 31, 2022 $81.34M
Net Income FY 2024 · Dec 31, 2022 −$79.97M
Operating Income FY 2024 · Dec 31, 2022 −$83.92M
Revenue FY 2024 · Dec 31, 2022 $9.29M
Stockholders Equity FY 2024 · Dec 31, 2021 $156.56M